719294-09-4

Basic information

• Product Name: methanesulfonic acid 3-{4-[4-(3-methanesulfonyloxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propyl ester
• Synonyms: methanesulfonic acid 3-{4-[4-(3-methanesulfonyloxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propyl ester
• CAS NO: 719294-09-4
• Molecular Weight: 594.617
• Mol File: 719294-09-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methanesulfonic acid 3-{4-[4-(3-methanesulfonyloxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: methanesulfonic acid 3-{4-[4-(3-methanesulfonyloxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propyl ester(719294-09-4)
• EPA Substance Registry System: methanesulfonic acid 3-{4-[4-(3-methanesulfonyloxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propyl ester(719294-09-4)

Safety Data

• Hazardous Substances Data: 719294-09-4(Hazardous Substances Data)

Upstream product

• 393-19-1 2,2'-bis(trifluoromethyl)-4,4'-diaminodiphenyl sulfide 
• 400-77-1 4-nitro-2-trifluoromethylthiophenol 
• 777-37-7 4-chloro-3-(trifluoromethyl)nitrobenzene 
• 719294-00-5 3-{4-[4-(2-carboxy-ethyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propionic acid 
• 719293-96-6 3-{4-[4-(3-hydroxy-propyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-propan-1-ol 
• 124-63-0 methanesulfonyl chloride 
• 719293-99-9 3-{4-[4-(2-carboxyvinyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-acrylic acid 
• 719293-98-8 3-{4-[4-(2-carboxyvinyl)-2-trifluoromethyl-phenylsulfanyl]-3-trifluoromethyl-phenyl}-acrylic acid dimethyl ester 
• 719293-97-7 4,4'-diiodo-2,2'-bis(trifluoromethyl)diphenylsulfide 

Relevant articles and documents

Novel compounds, their preparation and use

A novel class of dicarboxylic acid derivatives, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR).